CNS Startup Myrobalan Therapeutics Raises $24M Series A

By Yeji Jesse Lee · January 10, 2024, 7:10 PM EST

Biotech company Myrobalan Therapeutics announced Wednesday it has raised a $24 million series A to develop treatments for degenerative CNS conditions....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login